We are live on ! Find out more
PCM

Prelude Capital Management Portfolio holdings

AUM $1.31B
1-Year Est. Return 62.02%
This Fund
S&P 500
This Quarter Est. Return
+14.73%
1 Year Est. Return
+62.02%
3 Year Est. Return
+164.16%
5 Year Est. Return
+274.13%
10 Year Est. Return
+2,470.2%
AUM
$1.51B
AUM Growth
-$25.3M
Cap. Flow
-$166M
Cap. Flow %
-11.02%
Top 10 Hldgs %
21.48%
Holding
1,502
New
400
Increased
305
Reduced
321
Closed
403

Top Buys

Rank Stock Value
1
VIPS icon
Vipshop
VIPS
+$11.8M
2
EDU icon
New Oriental
EDU
+$11.7M
3
LI icon
Li Auto
LI
+$10.4M
4
HES
Hess
HES
+$9.96M
5
ACMR icon
ACM Research
ACMR
+$7.73M

Top Sells

Rank Stock Value
1
ATVI
Activision Blizzard
ATVI
+$20.8M
2
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
+$15.7M
3
TCOM icon
Trip.com Group
TCOM
+$13.1M
4
NEWR
New Relic, Inc.
NEWR
+$11.2M
5
VMW
VMware, Inc
VMW
+$9.66M

Sector Composition

Rank Sector Weight
1 Technology 14.24%
2 Consumer Discretionary 12.06%
3 Healthcare 10.13%
4 Industrials 10.12%
5 Energy 5.93%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
DAWN
426
DELISTED
Day One Biopharmaceuticals
DAWN
$621K 0.04%
42,500
+20,600
+94% +$250K
VICR icon
427
CALL
Vicor
VICR
$9.9B
$620K 0.04%
+13,800
New +$608K
CWEN icon
428
Clearway Energy Class C
CWEN
$6.72B
$620K 0.04%
+22,592
New +$527K
PRLB icon
429
Protolabs
PRLB
$2.12B
$619K 0.04%
15,891
+7,045
+80% +$228K
BL icon
430
BlackLine
BL
$1.7B
$619K 0.04%
9,906
-2,550
-20% -$144K
INBX
431
DELISTED
Inhibrx, Inc. Common Stock
INBX
$617K 0.04%
16,236
+3,015
+23% +$64.6K
BBIO icon
432
BridgeBio Pharma
BBIO
$16.7B
$616K 0.04%
15,254
+40
+0.3% +$1.2K
COP icon
433
PUT
ConocoPhillips
COP
$146B
$615K 0.04%
5,300
-2,800
-35% -$328K
RCKT icon
434
Rocket Pharmaceuticals
RCKT
$399M
$611K 0.04%
+20,400
New +$450K
NI icon
435
NiSource
NI
$20.1B
$610K 0.04%
22,965
-10,755
-32% -$276K
COLB icon
436
Columbia Banking Systems
COLB
$8.83B
$607K 0.04%
22,739
+5,164
+29% +$115K
BAH icon
437
Booz Allen Hamilton
BAH
$9.26B
$606K 0.04%
4,739
+1,304
+38% +$163K
HP icon
438
Helmerich & Payne
HP
$4.11B
$604K 0.04%
16,686
+6,412
+62% +$248K
SPG icon
439
PUT
Simon Property Group
SPG
$71B
$599K 0.04%
4,200
– –
WST icon
440
West Pharmaceutical
WST
$25.1B
$596K 0.04%
+1,694
New +$600K
MTSI icon
441
MACOM Technology Solutions
MTSI
$23.3B
$595K 0.04%
6,397
+3,046
+91% +$250K
CMS icon
442
CMS Energy
CMS
$21.8B
$593K 0.04%
+10,208
New +$570K
PG icon
443
Procter & Gamble
PG
$338B
$592K 0.04%
+4,038
New +$598K
HPQ icon
444
HP
HPQ
$27.5B
$591K 0.04%
+19,633
New +$550K
STE icon
445
Steris
STE
$23B
$588K 0.04%
2,676
+1,745
+187% +$369K
PGTI
446
DELISTED
PGT, Inc.
PGTI
$588K 0.04%
+14,440
New +$469K
ARW icon
447
Arrow Electronics
ARW
$10.3B
$583K 0.04%
+4,771
New +$569K
MAG
448
DELISTED
MAG Silver
MAG
$582K 0.04%
55,931
-5
-0% -$53
CHS
449
DELISTED
Chicos FAS, Inc.
CHS
$582K 0.04%
+76,751
New +$577K
ZIM icon
450
ZIM Integrated Shipping Services
ZIM
$3.1B
$576K 0.04%
+58,351
New +$490K
16 17
18
19 20

Similar funds

PFBT
Parkside Financial Bank & Trust Saint Louis, Missouri $1.31B AUM 19.14% 1-Year Est. Return
CCP
Clarkston Capital Partners Rochester, Michigan $1.31B AUM 3.79% 1-Year Est. Return
SP
Sherman Porfolios Coeur D'alene, Idaho $1.3B AUM 35.18% 1-Year Est. Return
HCS
Himension Capital (Singapore) Singapore $1.3B AUM 85.53% 1-Year Est. Return
SPC
Silver Point Capital Greenwich, Connecticut $1.3B AUM 18.3% 1-Year Est. Return
GPCM
Greenbrier Partners Capital Management Dallas, Texas $1.3B AUM 21.43% 1-Year Est. Return
MCM
Mainstay Capital Management Grand Blanc, Michigan $1.3B AUM 37.8% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return

Prelude Capital Management's Q4 2023 Portfolio in Review

As of Q4 2023, Prelude Capital Management held 1,502 positions worth $1.51B, down 1.6% from $1.53B the previous quarter. Its ten largest holdings account for 21% of the portfolio.

Prelude Capital Management withdrew a net $166M in Q4 2023, closing 403 positions and reducing 321 holdings. Its most notable exit was Activision Blizzard, an estimated $20.8M position sold in full.

By sector, the portfolio is most concentrated in Technology at 14% of assets, down from 15% a quarter earlier, followed by Consumer Discretionary and Healthcare.

Against the trend, Prelude Capital Management opened a new position in New Oriental worth $12.4M.

  • Prelude Capital Management's largest Q4 2023 buy was New Oriental: 168,713 shares worth $12.4M.
  • Prelude Capital Management added most to Vipshop in Q4 2023, an estimated $11.8M increase.
  • Prelude Capital Management's biggest Q4 2023 reduction was NVIDIA, cutting an estimated $7.3M.
  • Prelude Capital Management fully exited Activision Blizzard in Q4 2023, selling an estimated $20.8M.
  • Prelude Capital Management's ten largest holdings make up 21% of its $1.51B portfolio in Q4 2023.
  • Prelude Capital Management opened 400 new positions and closed 403 in Q4 2023.
  • Prelude Capital Management's portfolio value fell 1.6% quarter-over-quarter to $1.51B.

Based on Prelude Capital Management's 13F filing for Q4 2023, filed 14 Feb 2024.